Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2002

A radical approach to cancer.

Undurti Das

Med Sci Monit 2002; 8(4): RA79-92 :: ID: 420857

Abstract

Reactive oxygen species are known to be potentially dangerous, but arealso needed for signal-transduction pathways. Tumor cells have relatively low amounts of superoxide dismutase(SOD), which quenches superoxide anion (O2(-*)), and as a result of a higher level of aerobic metabolism,higher concentrations of O2(-*) , compared to normal cells. But this may not be true of all tumor cells.Some tumor cells have relatively higher amounts of vitamin E, a potent anti-oxidant, and a higher levelof anaerobic metabolism, resulting in a balance that is tilted more towards higher anti-oxidant capacity.In both instances of higher aerobic and anaerobic metabolism methods designed to augment free radicalgeneration in tumor cells can cause their death. It is suggested that free radicals and lipid peroxidessuppress the expression of Bcl-2, activate caspases and shorten telomere, and thus inducing apoptosisof tumor cells. Ionizing radiation, anthracyclines, bleomycin and cytokines produce free radicals andthus are useful as anti-cancer agents. But they also produce many side-effects. 2-methoxyoestradiol andpolyunsaturated fatty acids (PUFAs) inhibit SODs and cause an increase of O2(-*) in tumor cells leadingto their death. In addition, PUFAs (especially gamma-linolenic acid), 2-methoxyoestradiol and thalidomidemay possess anti-angiogenic activity. This suggests that free radicals can suppress angiogenesis. Limitedclinical studies done with gamma-linolenic acid showed that it can regress human brain gliomas withoutany significant side-effects. Thus, PUFAs, thalidomide and 2-methoxyoestradiol or their derivatives mayoffer a new radical approach to the treatment of cancer.

Keywords: Anaerobiosis, Angiogenesis Inhibitors, Cell Division, Fatty Acids, Unsaturated, Free Radicals, Lipid Peroxidation, Neoplasm Proteins, Neoplasms, Superoxides, Telomere, thalidomide, Vitamin E

Add Comment 0 Comments

Editorial

01 February 2025 : Editorial  

Editorial: Current Approaches to Screening for Lung Cancer in Smokers and Non-Smokers

Dinah V. Parums

DOI: 10.12659/MSM.948255

Med Sci Monit 2025; 31:e948255

0:00

In Press

Clinical Research  

Predicting Cerebral Small Vessel Disease Burden Based on Thromboelastography in Patients with Acute Ischemi...

Med Sci Monit In Press; DOI: 10.12659/MSM.946303  

Clinical Research  

Long-Term Outcomes of Implanon in Managing Adenomyosis: A 3-Year Prospective Study

Med Sci Monit In Press; DOI: 10.12659/MSM.945972  

Laboratory Research  

Linear Dimensional Accuracy in Maxillomandibular Records: A Comparative Study of Scannable and Transparent ...

Med Sci Monit In Press; DOI: 10.12659/MSM.947265  

Clinical Research  

Efficacy of King's Combined Uterine Suture in Managing Placenta Accreta: A Retrospective Analysis

Med Sci Monit In Press; DOI: 10.12659/MSM.945826  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,969,932

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   701,896

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Mar 2024 : Editorial   25,741

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...

DOI :10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

28 Jan 2024 : Review article   20,253

A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future

DOI :10.12659/MSM.943912

Med Sci Monit 2024; 30:e943912

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750